

KMR Group’s Best Places for Clinical Research report series ranks over 90 countries on clinical trial performance using data from over 5,000 trials in 2010-14. The reports are disease based and provide a detailed assessment of overall performance based on 8 key factors that assess patient access, recruitment, infrastructure and cost of doing business.
Each report provides a detailed evaluation of each country based on these factors both individually as well as in aggregate. Find out how your key countries rank on the global stage or within the region.
Check out the top 3 ranked countries by disease below based on each country’s aggregate global ranking. Want to see more than the top 3? The reports are available for purchase. For more information contact KMR Group.
Country Rankings By Disease – Top 3
- Alzheimer’s
-
USA
Russia
France - Arthritis
-
Poland
Czech Republic
Mexico - Asthma
-
Poland
USA
Bulgaria - Breast Cancer
-
France
South Korea
USA - Cardiovascular
-
Poland
Czech Republic
China - Cholesterol & Lipid Disorders
-
USA
Germany
Netherlands - CNS
-
Poland
USA
Russia - Colorectal Cancer
-
USA
Spain
China - Coronary Dysfunction
-
Poland
China
Netherlands - Dermatology
-
USA
Poland
Canada - Diabetes – Type II
-
Mexico
Romania
Hungary - Gastroenterology
-
USA
Poland
China - Gastrointestinal Cancer
-
South Korea
USA
Taiwan - Hematologic Cancer
-
USA
France
Italy - Hepatitis C
-
USA
Canada
Germany - Hypertension
-
China
USA
Germany - Lung Cancer
-
China
Germany
Poland - Oncology
-
China
USA
South Korea - Pain
-
USA
Germany
Netherlands - Psychiatric
-
USA
Russia
Poland - Respiratory
-
USA
Poland
China

